Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
To access this article, please choose from the options below
View this article's video abstract at www.gastrojournal.org.
Conflicts of interest The authors disclose no conflicts.
Funding The Swiss Hepatitis C and HIV Cohort Studies are supported by the Swiss National Science Foundation (3347C0-108782/1, grant nos. 3347-069366, 3247-116862, and 3100AO-116323/1, and Swiss HIV Cohort Study grant 543), the Swiss Federal Office for Education and Sciences (03.0599), and the European Commission (LSHM-CT-2004-503359; VIRGIL Network of Excellence on Antiviral Drug Resistance). Genotyping in the Swiss Hepatitis C Cohort Study and statistical analyses were supported by the Leenaards Foundation and Debiopharm S.A. Genotyping in the Swiss HIV Cohort Study was supported by an unrestricted grant by Essex Chemie AG, the Novaris Research Foundation, and Infectigen, Switzerland. P.-Y.B. is supported by the Swiss National Science Foundation (32003B_127613/1), and the Leenaards Foundation.
PII: S0016-5085(10)00008-9
doi:10.1053/j.gastro.2009.12.056
© 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Interleukin-28b: A Key Piece of the Hepatitis C Virus Recovery Puzzle , 24 February 2010

